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ABSTRACT 
The aim of the present study was to investigate the effects of crocin - a natural antioxidant 
derived from saffron - on cardiac reperfusion-induced arrhythmia and antioxidant systems 
such as catalase and superoxide dismutase (SOD) enzyme activities, glutathione (GSH) and 
malondialdehyde (MDA, as a marker of lipid peroxidation) levels. 
Rats in 4 experimental groups were administered crocin (20 mg/kg/day) or vehicle (i.p.) for 
21 days with or without cardiac ischemia-reperfusion (IR). At the end of this period, hearts of 
anaesthetized animals in IR and “Cr + IR” groups were subjected to 10 min occlusion of the 
left anterior descending coronary artery and thereafter reperfused for 30 min. 
The results suggest that crocin is partially capable of suppressing reperfusion-induced ar-
rhythmias. Compared to control group, ischemic-reperfusion injury significantly decreased 
SOD activity and GSH level and increased MDA level of heart muscle. “Cr + IR” group 
showed remarkably increased catalase activity in heart tissue (28.7 ± 6.6 vs. 23.6 ± 4.1 U/mg 
protein, P < 0.05) compared to the IR group. The level of cardiac tissue SOD activity in the 
“Cr + IR” group animals did not decline significantly compared to rats that were administered 
crocin alone with no ischemia.  
The results suggest a protective role of crocin on cardiac reperfusion arrhythmias which may 
at least partially be related to stability or even amplification of antioxidant systems. Crocin 
may potentially be useful for treatment or prevention of arrhythmias in patients with ischemic 
heart disease and this issue remains to be investigated in future clinical studies.  
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♦ This paper is part of a MSc thesis by Zahra Jahanbakhsh. 
EXCLI Journal 2012;11:20-29 – ISSN 1611-2156 
Received: December 03, 2011, accepted: January 29, 2012, published: February 08, 2012 
 
21 
INTRODUCTION 
Reperfusion-induced arrhythmias are 
among the common causes of sudden cardi-
ac death and can be produced both in exper-
imental animals and humans (Bernier et al., 
1986; Foadoddini et al., 2010). Therefore, 
investigating new methods for minimizing 
sudden cardiac death caused by reperfusion 
arrhythmias has very important clinical rel-
evance. 
Reactive oxygen species (ROS), which 
are increased after a few minutes of reper-
fusion, are one of the most important fac-
tors in pathophysiology of cardiac ischem-
ic-reperfusion (IR) injury. Various studies 
have reported the beneficial effects of dif-
ferent antioxidants as agents for reducing 
heart IR injury (Dhallaa et al., 2000). For 
example it has been reported that antioxi-
dants might be useful as adjuvants in con-
trolling reperfusion-induced arrhythmias 
following therapeutic thrombolysis (Hicks 
et al., 2007). 
Crocus sativus L., known as saffron, is 
a small perennial plant from the Iridaceae 
family. The main active constituent of saf-
fron is picrocrocin and its derivatives in-
cluding safranal, flavonoid derivatives and 
crocins (Boskabady et al., 2008). Crocin (a 
water soluble carotenoid) is the most abun-
dant antioxidant among active constituents 
of C. sativus (Goyal et al., 2010). It has 
been documented that crocin has protective 
effects in brain (Zheng et al., 2007), skele-
tal muscle (Hosseinzadeh et al., 2009) and 
kidney ischemia-reperfusion injury models 
via its antioxidant properties (Hosseinzadeh 
et al., 2005). Twice a day administration of 
50 milligrams of saffron – dissolved in 
100 ml of milk – to human patients with 
coronary artery disease leads to significant 
decrease in lipoprotein oxidation suscepti-
bility; which indicates the potential of saf-
fron as an antioxidant (Srivastava et al., 
2010). A lowering effect on blood pressure 
and relaxant effects on vascular smooth 
muscle were also described for this plant 
(Boskabady et al., 2008). 
Based on the documented protective 
role of antioxidant agents against cardiac 
arrhythmias and the potential antioxidant 
property of crocin, it is hypothesized in this 
study that crocin may reduce reperfusion-
induced arrhythmias. Thus, the present 
study was planned to examine the effects of 
crocin on reperfusion-induced arrhythmias 
and antioxidant systems in an in vivo is-
chemic reperfusion (IR) injury model.  
 
MATERIALS AND METHODS 
Animals 
Male Wistar rats weighing 200 to 250 g 
were housed under standard conditions with 
free access to food and water. The investi-
gation was performed in accordance with 
the Guide for the Care and Use of Labora-
tory Animals published by the National In-
stitutes of Health (Cohen et al., 1970), and 
was approved by the Animal Ethics Com-
mittee of Baqiyatallah University. 
 
Experimental groups 
The rats were assigned randomly to four 
groups: IR (n = 18), “Cr + IR” (n = 18), 
Control (n = 10) and Crocin (n = 10) 
groups. In the IR and control groups, rats 
received normal saline (1cc/kg, i.p) once a 
day for 3 weeks. In “Cr + IR” and crocin 
groups, rats were treated with crocin (Sig-
ma, Japan) (20 mg/kg, i.p) once a day for 3 
weeks. The dosage of crocin was deter-
mined according to other studies (Zheng et 
al., 2007; Goyal et al., 2010). On the 21st 
day, 1 h after administering the above 
treatments, the rats in the IR and “Cr + IR” 
groups were subjected to 10 min of left an-
terior descending coronary artery (LAD) 
occlusion followed by 30 min reperfusion. 
In the crocin and control groups, all steps 
were similar to IR groups except for the oc-
clusion of LAD to induce ischemia. 
 
Surgical procedure 
Coronary artery occlusion and reperfu-
sion was performed according to the meth-
od described by Foadoddini et al. (2010) 
and Baharvand et al. (2010).  
In brief, rats were anaesthetized with 
sodium pentobarbital (Sigma, St. Louis, 
MO) (30 mg/kg, ip) and ketamine (Alfasan, 
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Holland) (40 mg/kg, ip). Rectal temperature 
was continuously monitored and main-
tained at 37 ± 0.5 °C. The neck was opened 
with a ventral midline incision and a tra-
cheotomy was performed. The rats were 
artificially ventilated with room air en-
riched with oxygen at a rate of 80 per min 
and tidal volume of 1 ml 100gـ1 to maintain 
blood PO2, PCO2 and pH in the normal 
physiological ranges. A standard limb lead 
II electrocardiogram was monitored and 
recorded throughout the experiment. A 
catheter was inserted into the left carotid 
artery for monitoring of blood pressure. A 
left thoracotomy was performed in the 
fourth intercostal space, and pericardium 
was opened to expose the heart. A 6-0 silk 
suture was passed around the left anterior 
coronary artery (LAD) and the ends of it 
were threaded through a small polyethylene 
tube to form a snare.  
Following a stabilization period of 
20 min, the artery was occluded for 10 min 
by clamping the snare against the surface of 
the heart. Ischemia was confirmed by re-
gional cyanosis and ST elevation in the 
electrocardiogram (ECG). Reperfusion was 
established by releasing the snare for 
30 min. It is generally believed that reper-
fusion after 3–10 min of ischemia results in 
life-threatening arrhythmia in anaesthetized 
rats (Kajiwara et al., 2005). 
 
Assessment of ventricular arrhythmias 
Ischemia-induced ventricular arrhyth-
mias were determined in accordance with 
the Lambeth conventions (Walker et al., 
1988): premature ventricular beat (VEB) as 
a discrete and identifiable premature QRS 
complex (premature with respect to the P 
wave), ventricular tachycardia (VT) as a 
run of four or more VEB at a rate faster 
than the resting sinus rate and ventricular 
fibrillation (VF) as a signal for which indi-
vidual QRS deflection can no longer be dis-
tinguishable from one another. Complex 
forms (bigeminy and salvos) were added to 
VEB count and not analyzed separately. 
 
Biochemical studies 
Immediately following to reperfusion 
period, the heart was excised and cleared of 
blood by rinsing in cold isotonic saline. In 
the IR and “Cr + IR” groups, the ischemic 
area was cut out whilst in the sham-
operated animals the corresponding left 
ventricular region was taken. Only these 
tissue samples were snap frozen in liquid 
nitrogen, stored at -80 °C and used for glu-
tathione (GSH), malondialdehyde (MDA), 
superoxide dismutase (SOD) and catalase 
assays. On the day of use, frozen tissue 
samples were quickly weighed and homog-
enized 1:10 in ice-cold phosphate-buffer 
saline (PBS). The homogenates were then 
centrifuged at 14000×g for 15 min at 4 °C. 
The supernatants were separated and used 
for enzyme activities assays and protein de-
termination.  
GSH level was measured using the 
method of Tietze (1969). 
Catalase activity was measured in tis-
sues homogenates by the method of Aebi 
(1984). The activity of SOD was deter-
mined according to Winterbourn et al. 
(1975) and is based on the ability of super-
oxide dismutase to inhibit the reduction of 
nitro-blue tetrazolium (NBT) by superox-
ide. The end product of lipid peroxidation 
was estimated by measuring the level of 
MDA according to the method of Satoh 
(1978). 
 
Protein assay 
Total protein concentration was meas-
ured by Bradford’s method (Bradford, 
1976) using bovine serum albumin as a 
standard. 
 
Statistical analysis 
Data are shown as Mean ± SEM or per-
centage of incidence. The mean values were 
compared by independent sample T- test or 
one-way ANOVA (Tukey’s post-hoc test). 
Fisher’s exact test was used to compare 
the differences in the incidence of VF be-
tween groups.  
P-value < 0.05 was considered signifi-
cant statistically. 
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RESULTS 
Hemodynamic parameters 
Table 1 summarizes the hemodynamic 
data. There were no significant differences 
at baseline values for heart rate and mean 
arterial blood pressure (MBP) among the 
experimental groups. Ischemia caused a 
marked reduction in blood pressure and the 
pressure remained at this reduced level dur-
ing reperfusion period. 
 
Effects of crocin on reperfusion-induced 
arrhythmias 
Crocin significantly reduced the number 
of VEBs compared with the IR group (p < 
0.05).The number of VEBs were 31.1 ± 6.8 
in the IR group and 12.6 ± 2.2 in the Cr+IR 
group (Figure 1). Crocin also reduced the 
VT episodes significantly compared with 
the IR group (p < 0.01). The number of VT 
episodes and VT duration were 4.3 ± 0.6 
and 25.6 ± 6 s in the IR group, 2.2 ± 0.5 and 
16.5 ± 4 s in the Cr+IR group (Figure 2), 
respectively. VF incidence is decreased 
significantly by crocin as compared to the 
IR group (p < 0.05). It was 67 % (12 of 18) 
in the IR group and 34 % (6 of 18) in the 
Cr+IR group (Figure 3).  
 
Antioxidant enzymes activities 
Figure 4A shows mean heart tissue 
SOD activity. It was significantly lower in 
IR than control group (21.9 ± 5 vs. 29.7 ± 
3.1 unit/mg protein, P < 0.01). The level of 
SOD activity in “Cr + IR” group did not 
have any significant difference compared to 
Crocin group (24.9 ± 4.7 vs 28.1 ± 
3.5 unit/mg protein, P > 0.05). Figure 4B 
shows mean heart tissue catalase activity. 
Catalase activity decreased insignificantly 
in IR compared to the control group (23.6 ± 
4.1 vs. 26.7 ± 3.5 units/mg protein, P = 
0.054). Administration of crocin for 
21 days significantly increased catalase ac-
tivity compared to IR (28.9 ± 6.5 vs 23.6 ± 
4.1 units/mg protein, P < 0.05). 
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Figure 1: VEB numbers (as Mean ± SEM) dur-
ing 30 min reperfusion following 10 min ische-
mia in anaesthetized rats. IR, Ischemic-
Reperfusion group; Cr+IR, group in which ad-
ministration of crocin for 21 days was done be-
fore ischemia-reperfusion. * P < 0.05 versus IR 
group 
 
 
 
Figure 2: Ventricular tachycardia (VT) episodes and duration (seconds) during 30 min reperfusion 
following 10 min ischemia in rats. IR, Ischemic-Reperfusion group; Cr+IR, group in which administra-
tion of crocin for 21 days was done before ischemia-reperfusion. Data are shown as mean ± SEM.  
** P < 0.01 versus IR group 
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Figure 4: Heart superoxide dismutase (SOD) (A) and catalase (CAT) activities (B) and heart glutathi-
one (GSH) (C) and malondialdehyde (MDA) (D) levels following 10 min of ischemia and 30 min reper-
fusion. Data was shown as Mean ± SD.  
* P < 0.05 compared to control group 
** P < 0.01 compared to control group 
#  P < 0.05 compared to IR group 
Figure 3: The incidence percentage 
of ventricular fibrillation (VF) during 
30 min reperfusion following 10 min 
ischemia in anaesthetized rats. IR, 
Ischemic-Reperfusion group; Cr+IR, 
group in which administration of 
crocin for 21 days was done before 
ischemia-reperfusion. Data are shown 
as Mean ± SEM.  
* P < 0.05 versus IR group 
**
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Table 1: Hemodynamics parameters in experimental groups 
Groups Baseline 
HR              MBP 
Ischemia 
HR               MBP 
Reperfusion 
HR              MBP 
IR 359 ± 8 122 ± 3 353 ± 9 104 ± 4* 316 ± 17 75 ± 5*** 
Cr+IR 350 ± 9 124 ± 6 344 ± 11 108 ± 6** 325 ± 11 87 ± 3*** 
 
Data presented as Mean ± SEM. HR, heart rate (beat per min); MBP, mean arterial blood pressure 
(mmHg); IR, Ischemic-Reperfusion group, Cr+IR, group in which administration of crocin for 21 days 
was done before ischemia-reperfusion. 
* p < 0.05 
** p < 0.01 compared with the baseline within the same group 
 
 
GSH and MDA levels 
Figure 4C shows that ischemia-reper-
fusion caused a significant decrease in heart 
tissue GSH level (9.3 ± 1.4 vs. 11.6 ± 
1.6 nmol/mg protein, P < 0.01). Figure 4D 
shows that MDA level was significantly 
higher in IR group compared with Control 
group (11.7 ± 1.5 vs. 9.5 ± 1.47 nmol/mg 
protein, P < 0.5). However, as shown Fig-
ures 4C and 4D, GSH and MDA levels in 
Cr+IR and IR groups were not significantly 
different (9.8 ± 0.9) and 12.5 ± 
1.7 nmol/mg protein, respectively. 
 
DISCUSSION 
The present results show that in vivo 
reperfusion-induced arrhythmias are pre-
vented by 21 days pretreatment of rats with 
crocin at a dose of 20 mg/kg with no signif-
icant alteration in hemodynamic parame-
ters. This antiarrhythmic effect may have 
been partially exerted by stabilization of 
SOD levels and by amplification of catalase 
activity during IR injury. 
The clinical importance of reperfusion 
arrhythmias is related to their documented 
role in sudden cardiac death. VT and VF 
during reperfusion period remain the most 
important causes of sudden death. In fact, 
reperfusion-induced arrhythmias are unre-
sponsive to antiarrhythmic drugs with po-
tential benefit in ischemia (Manning and 
Hearse, 1984). Meanwhile, the standard an-
tiarrhythmic drugs have limitations arising 
from their proarrhythmic and potentially 
toxic effects (Zhao et al., 2010). Thus, re-
search to finding new agents and treatment 
modalities for reperfusion arrhythmias are 
among the most important basic and clini-
cal studies. 
Generally, reperfusion-induced ar-
rhythmias are believed to occur due to 
overproduction of oxygen-derived free rad-
icals and calcium overload during the first 
minutes of reflow (Zhao et al., 2010). Nu-
merous antioxidants have been shown to 
prevent reperfusion induced arrhythmias in 
various animal species (Bernier et al., 1986; 
Takusagawa et al., 2000). Also treatment 
with diltiazem (a known calcium channel 
blocker), could be effective in prevention of 
reperfusion-induced arrhythmias (Kajiwara 
et al., 2005). 
Previous investigations suggested that 
some constituents of C. sativus (saffron) 
might have antioxidant properties (Abdul-
laev and Espinosa-Aguirre, 2004). Crocin is 
the most important and abundant antioxi-
dant among the pharmacologically active 
constituents of C. sativus. Also aqueous-
ethanol extract of C. Sativus, via its calcium 
channel-blocking properties, has potent in-
hibitory effect on contractility and rate of 
guinea pig heart (Boskabady et al., 2008). 
Furthermore, saffron and crocin have hypo-
tensive (Imenshahidi et al., 2010) and hypo-
lipidemic properties via augmentation of 
antioxidant activities (Asdaq and Inamdar, 
2010). In the present study, prevention of 
arrhythmias was observed with intraperito-
neal administration of 20 mg/kg/day of 
crocin in rat. The mechanism of action of 
crocin might be related to antioxidant or 
calcium channel-blocking effect and further 
electrophysiological studies are required to 
elucidate exactly how this agent prevents 
ventricular arrhythmias. 
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Most of previous studies in various or-
gans emphasize on suppression of nearly all 
antioxidant defence systems, including 
lower SOD and catalase enzymes activities 
and lower GSH level following IR (Li and 
Jackson, 2002; Rasoulian et al., 2008). Su-
peroxide dismutase (SOD) and catalase 
(CAT) are the most important antioxidant 
enzymes of tissues. Glutathione (GSH), a 
free radical scavenger, plays an important 
role in maintenance of cellular redox envi-
ronment (Rasoulian et al., 2008). A de-
crease in the activity of SOD and CAT can 
result in the decreased removal of superox-
ide ion (O2-) and hydrogen peroxide (H2O2) 
radicals (Rao and Vismanath, 2007). Su-
peroxide radicals are among the most im-
portant reactive oxygen species responsible 
for IR injury and could be converted to 
H2O2 by SOD activity. H2O2 itself is inacti-
vated by glutathione peroxidase (GPX) and 
catalase (Paller et al., 1984). In this study, 
there was a decrease in heart SOD activity 
and GSH level following myocardial IR in 
accordance with published data (Li and 
Jackson, 2002; Abdullaev and Espinosa-
Aguirre, 2004). The decreased GSH level 
could be explained by its consumption for 
scavenging free radicals and maintaining 
the redox state of the cell during IR period 
(Schafer and Buettner, 2001). 
Catalase and SOD activities were re-
covered in the crocin treated group. The 
increase of Catalase activity by crocin in 
the IR-groups suggests that crocin has an 
important role in modulating antioxidative 
effects. Asdag and Inamdar (2010) reported 
that crocin could return SOD and catalase 
activity to normal values in liver tissues of 
rats subjected to hyperlipidemic stress. 
Ochiai et al. (2007) and Saleem et al. 
(2006) in two independent studies showed 
protective roles for saffron and its carote-
noid components on neuronal cell injuries 
in vivo and in vitro. In another experiment, 
Hosseinzadeh et al. (2005) demonstrated 
that saffron extract and its active constitu-
ent, crocin, have protective effects on IR-
induced oxidative stress in rat kidney. It has 
been documented that saffron consumption 
prevents cardiac injury and leads to de-
creased serum levels of cardiac troponin I 
in rats subjected to isoproterenol induced 
myocardial injury (Joukar et al., 2010). 
Based on antioxidant properties of crocin, it 
could be suggested that cardioprotective 
effects of saffron may at least partially be 
related to antioxidant activity of its natural 
constituent, crocin. 
We also assessed the effect of crocin on 
lipid peroxidation by measuring MDA, a 
stable metabolite resulting from free radical 
mediated lipid peroxidation. MDA level 
was increased significantly following myo-
cardial IR injury, as have been reported in 
previous studies (Dhalla et al., 1999, 2000). 
Cardiac preconditioning decreases MDA 
formation after prolonged ischemia and 
reperfusion (Turrens et al., 1992). However, 
crocin did not decrease MDA level in pre-
sent study. 
We used the i.p.-route for crocin admin-
istration because it was previously reported 
that orally administered crocin was hardly 
absorbed into the blood circulation in ro-
dents (Asai et al., 2005). Crocin is easily 
transformed to crocetin by the intestinal 
bacteria of human or mouse (Lee et al., 
2005). So, crocins are hydrolyzed to croce-
tin before or during intestinal absorption, 
and absorbed crocetin is partly metabolized 
to mono- and diglucuronide conjugates 
(Asai et al., 2005). Li et al. (2002) reported 
that large amounts of crocin were eliminat-
ed via feces after oral administration. 
Crocin remained undetectable in plasma, 
further indicating that the intact form of 
crocin was not absorbed from the intestinal 
tract. Meanwhile, the plasma concentrations 
of crocetin after oral dose(s) of crocin were 
found to be low (Xi et al., 2007). This indi-
cates that crocetin was rapidly removed 
without accumulation in the body, which is 
consistent with the short plasma half-life of 
crocetin (Liu and Qian, 2002). These are 
important aspects for therapeutic crocin ap-
plications. 
In conclusion, the present experiment 
showed that crocin protects against severe 
reperfusion-induced arrhythmias in rat 
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hearts in vivo and this could be partly relat-
ed to stability or amplification of antioxi-
dant system. Supplementary studies are re-
quired for clarifying the entire aspects of 
crocin effects on heart. 
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